Final iExam 1) Ai40-
year iold ifemale ipatient iisibeing ifollowed iup ifor idiabetes imellitus. iShe iisicurrently ion iMetformin i1igram it
wice iaiday iand ihas ibeen itolerating iitiwell ifor iabout isix imonths. iHer ihemoglobin iA1c iaiweek iago iwas i8.9%
.iThe iplan iisitoiinitiate iliraglutide itherapy iiniaddition itoithe imetformin. iWhich iofithe ifollowing istatemen
tsiisitrue iwith iregards itoiliraglutide. ▪ Liraglutide imay ibe istored iinithe irefrigerator iorifreezer iprior itoifirst iuse. ▪ The ibrand iname iisiBydureon ▪ Nausea iand/or ivomiting iare icommon iside ieffects iofitherapy ▪ Itishould ibe iadministered iintramuscularly iinto ithe iupper iarm. 2) The ipatient iwho itakes iinsulin ihas ijust ibeen iprescribed iaibeta iblocker idrug. iYou irecognize ithat ithe iint
eraction iofithe ibeta iblocker iand ithe iinsulin imay ihave iwhich iresult? ▪ Decreased iactivity iofithe ibeta iblocker idrug ▪ Enhanced iactivity iofithe ibeta iblocker idrug ▪ Masked isigns iofihypoglycemia ▪ Masked isigns iofihyperglycemia 3) The idrug iofichoice ifor itype i2idiabetics iisimetformin. iMetformin: ▪ Increases iintestinal iuptake iofiglucose ▪ Decreases iglycogenolysis iby ithe iliver ▪ Increases ithe irelease iofiinsulin ifrom ibeta icells ▪ Prevents iweight igain iassociated iwith ihyperglycemia 4) Which iclassification iofioral ihypoglycemic idrugs idecreases ihepatic iglucose iproduction iand iincrease
siinsulin isensitivity iand iperipheral iglucose iuptake? ▪ Sulfonylureas i(glyburide) ▪ Meglitinides i(glinides) ▪ Bigua nide i(metformin) ▪ alpha -glycosidase iinhibitor i(miglitol) 5) Aibreast -feeding imother iisiseen iiniyour iclinic iwanting icontraceptive iand iplans ion ibreast -
feeding ifor iaiyear. iWhat iisian iinappropriate ichoice ifor ithis ipatient? ▪ Depo -Provera i150mg iIM ievery i3imonths ▪ Prog estin -only iOC ▪ Combination iOC ▪ Intrauterine idevice 6) Which iofithe ifollowing iisi(are) itrue iabout ioral icontraceptives i(OCs)? ▪ Estrostep, iOrtho iTri-Cyclen, iBeyaz, iand iYAZ iare iapproved ifor imanaging iacne iiniwomen ▪ All ithe ianswrs iare icorrect ▪ OCs ifavorably iaffect imenstrual isymptoms: icramps ireduction, ireduced imenstrual iflow ivolume iand idur
ation. ▪ OCs idecrease ithe irisk ifor iseveral idisorders, iincluding iovarian icancer, iendometrial icancer, iovarian icys
ts, ipelvic iinflammatory idisease, ibenign ibreast idisease. 7) Aipatient iisiprescribed iehtinyl iestradiol iand inorelgestromin itransdermal icontraceptive ipatch. iW
hich istatement, iIfimade iby ithe ipatient, iindicates ian iunderstanding iofithe iuse iofithis idrug? ▪ “The ipatch iprevents ipregnancy iby iacting iasibarrier.” ▪ “Iiwill iexperience iminimal iside ieffects ibecause iitiisiaiprogestin -only idevice.” ▪ “Iiwill iremove ithe ipatch ieach imonth iand ireplace iitiwith iainew ipatch i1iweek ilater.” ▪ “Iiwill iapply ithe ipatch iinimy ivaginal iarea iprior itoihaving isexual iintercourse.” 8) The iNP iatithe iimmunization iclinic iisireviewing ithe ilist iofipatients iwho iare ischeduled itoireceive ithe ivar
icella ivaccination. iThe iNP iwill icancel iall iofithe ifollowing ipatients iexcept: ▪ Ai21-year iold ipatient iwho iisiallergic itoineomycin ▪ Ai12-year iold ipatient iwithian iallergy itoigelatin ▪ An i8-year iold ipatient iwith iasthma ▪ Aipatient iwho iisipregnant 9) The irecommended irange ifor imaintaining iserum itheophylline ilevels iis: ▪ 20 itoi25 iug/ml ▪ 30 itoi40 iug/ml ▪ 0.05 itoi2iug/ml ▪ 10 itoi20 iug/ml 10) For ihis iasthma, iaipatient iisiprescribed ialbuterol iinithe iform iofian iinhalant. iThe ipatient itells iyou ithe i
medication icauses ishakes iand ihand itremors. iWhat iisithe ibest iresponse? ▪ “Iiwill icontact ithe irespiratory itherapist iabout iyour iproblem.” ▪ “Tremors iare ithe imost icommon iside ieffect iofithis iinhalant iand iwill iusually ifade iover itime.” ▪ “The itremors iare iprobably inot irelated itoithe imedication.” ▪ “iIiwill icontact iyour iprovider iabout iyour iproblem.” 11) Aipatient iwith iCOPD iisiacutely ihypercapneic. iWhich irespiratory itherapy ishould iyou iprescribe itoil
ower ithe ipatient’sicarbon idioxide iconcentration? ▪ Salmeterol ▪ Oxygen ivia iainasal icannula i2L/minute ▪ Fluticasone ipropionate ▪ Albuterol inebulizer 12) Aipatient ihas ibeen idiagnosed iwith ireflux iesophagitis i(GERD). iWhat iinstruction iby ithe iNP iisimost ia
ppropriate? ▪ Exercise isoon iafter ieating itoiincrease igastric iemptying ▪ You ineed itoischedule ian iupper iGI iendoscopy isoon. ▪ Try ithese iproton -pump iinhibitors ifor i2iweeks. ▪ Over -the-icounter iantiemetics iwork iwell ifor ithis icondition
year iold ifemale ipatient iisibeing ifollowed iup ifor idiabetes imellitus. iShe iisicurrently ion iMetformin i1igram it
wice iaiday iand ihas ibeen itolerating iitiwell ifor iabout isix imonths. iHer ihemoglobin iA1c iaiweek iago iwas i8.9%
.iThe iplan iisitoiinitiate iliraglutide itherapy iiniaddition itoithe imetformin. iWhich iofithe ifollowing istatemen
tsiisitrue iwith iregards itoiliraglutide. ▪ Liraglutide imay ibe istored iinithe irefrigerator iorifreezer iprior itoifirst iuse. ▪ The ibrand iname iisiBydureon ▪ Nausea iand/or ivomiting iare icommon iside ieffects iofitherapy ▪ Itishould ibe iadministered iintramuscularly iinto ithe iupper iarm. 2) The ipatient iwho itakes iinsulin ihas ijust ibeen iprescribed iaibeta iblocker idrug. iYou irecognize ithat ithe iint
eraction iofithe ibeta iblocker iand ithe iinsulin imay ihave iwhich iresult? ▪ Decreased iactivity iofithe ibeta iblocker idrug ▪ Enhanced iactivity iofithe ibeta iblocker idrug ▪ Masked isigns iofihypoglycemia ▪ Masked isigns iofihyperglycemia 3) The idrug iofichoice ifor itype i2idiabetics iisimetformin. iMetformin: ▪ Increases iintestinal iuptake iofiglucose ▪ Decreases iglycogenolysis iby ithe iliver ▪ Increases ithe irelease iofiinsulin ifrom ibeta icells ▪ Prevents iweight igain iassociated iwith ihyperglycemia 4) Which iclassification iofioral ihypoglycemic idrugs idecreases ihepatic iglucose iproduction iand iincrease
siinsulin isensitivity iand iperipheral iglucose iuptake? ▪ Sulfonylureas i(glyburide) ▪ Meglitinides i(glinides) ▪ Bigua nide i(metformin) ▪ alpha -glycosidase iinhibitor i(miglitol) 5) Aibreast -feeding imother iisiseen iiniyour iclinic iwanting icontraceptive iand iplans ion ibreast -
feeding ifor iaiyear. iWhat iisian iinappropriate ichoice ifor ithis ipatient? ▪ Depo -Provera i150mg iIM ievery i3imonths ▪ Prog estin -only iOC ▪ Combination iOC ▪ Intrauterine idevice 6) Which iofithe ifollowing iisi(are) itrue iabout ioral icontraceptives i(OCs)? ▪ Estrostep, iOrtho iTri-Cyclen, iBeyaz, iand iYAZ iare iapproved ifor imanaging iacne iiniwomen ▪ All ithe ianswrs iare icorrect ▪ OCs ifavorably iaffect imenstrual isymptoms: icramps ireduction, ireduced imenstrual iflow ivolume iand idur
ation. ▪ OCs idecrease ithe irisk ifor iseveral idisorders, iincluding iovarian icancer, iendometrial icancer, iovarian icys
ts, ipelvic iinflammatory idisease, ibenign ibreast idisease. 7) Aipatient iisiprescribed iehtinyl iestradiol iand inorelgestromin itransdermal icontraceptive ipatch. iW
hich istatement, iIfimade iby ithe ipatient, iindicates ian iunderstanding iofithe iuse iofithis idrug? ▪ “The ipatch iprevents ipregnancy iby iacting iasibarrier.” ▪ “Iiwill iexperience iminimal iside ieffects ibecause iitiisiaiprogestin -only idevice.” ▪ “Iiwill iremove ithe ipatch ieach imonth iand ireplace iitiwith iainew ipatch i1iweek ilater.” ▪ “Iiwill iapply ithe ipatch iinimy ivaginal iarea iprior itoihaving isexual iintercourse.” 8) The iNP iatithe iimmunization iclinic iisireviewing ithe ilist iofipatients iwho iare ischeduled itoireceive ithe ivar
icella ivaccination. iThe iNP iwill icancel iall iofithe ifollowing ipatients iexcept: ▪ Ai21-year iold ipatient iwho iisiallergic itoineomycin ▪ Ai12-year iold ipatient iwithian iallergy itoigelatin ▪ An i8-year iold ipatient iwith iasthma ▪ Aipatient iwho iisipregnant 9) The irecommended irange ifor imaintaining iserum itheophylline ilevels iis: ▪ 20 itoi25 iug/ml ▪ 30 itoi40 iug/ml ▪ 0.05 itoi2iug/ml ▪ 10 itoi20 iug/ml 10) For ihis iasthma, iaipatient iisiprescribed ialbuterol iinithe iform iofian iinhalant. iThe ipatient itells iyou ithe i
medication icauses ishakes iand ihand itremors. iWhat iisithe ibest iresponse? ▪ “Iiwill icontact ithe irespiratory itherapist iabout iyour iproblem.” ▪ “Tremors iare ithe imost icommon iside ieffect iofithis iinhalant iand iwill iusually ifade iover itime.” ▪ “The itremors iare iprobably inot irelated itoithe imedication.” ▪ “iIiwill icontact iyour iprovider iabout iyour iproblem.” 11) Aipatient iwith iCOPD iisiacutely ihypercapneic. iWhich irespiratory itherapy ishould iyou iprescribe itoil
ower ithe ipatient’sicarbon idioxide iconcentration? ▪ Salmeterol ▪ Oxygen ivia iainasal icannula i2L/minute ▪ Fluticasone ipropionate ▪ Albuterol inebulizer 12) Aipatient ihas ibeen idiagnosed iwith ireflux iesophagitis i(GERD). iWhat iinstruction iby ithe iNP iisimost ia
ppropriate? ▪ Exercise isoon iafter ieating itoiincrease igastric iemptying ▪ You ineed itoischedule ian iupper iGI iendoscopy isoon. ▪ Try ithese iproton -pump iinhibitors ifor i2iweeks. ▪ Over -the-icounter iantiemetics iwork iwell ifor ithis icondition
